Analyst Upgrades: Box, PlasmaTech, and Rite Aid

Analysts upwardly revised their ratings and price targets on Box Inc (NYSE:BOX), Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI), and Rite Aid Corporation (NYSE:RAD)

Jun 11, 2015 at 9:23 AM
facebook X logo linkedin


Analysts are weighing in today on cloud concern Box Inc (NYSE:BOX), drugmaker Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI), and pharmacy chain Rite Aid Corporation (NYSE:RAD). Here's a quick roundup of today's bullish brokerage notes on BOX, PTBI, and RAD.

  • BOX is exploding ahead of the open, as the company reported stronger-than-expected first-quarter numbers and raised its full-year forecast, after adding 2,000-plus subscribers during the quarter. Canaccord Genuity has since raised its price target to $21 from $20, and the shares are 12.9% higher in pre-market action. After settling at $17.79 yesterday, Box Inc is now set to open above $20 -- reaching its highest level since late March -- and short sellers are likely sweating. Nearly 10% of the stock's float is sold short, representing close to 12 days of buying power, at its normal trading pace. Analysts, too, have skeptical outlooks. Every single brokerage firm with coverage on BOX says it's a "hold."

  • PTBI is positioned 12.3% higher in electronic trading, thanks to Roth Capital, which started the stock with a "buy" rating and $16 price target. The shares are accustomed to huge jumps, as they've more than doubled since early May. Plasmatech Biopharmaceuticals Inc was last seen at $7.07, and even with these recent gains, it's still far removed from its annual high of $17.50, touched exactly one year ago. Roth Capital expects a return to double-digit levels -- and it's not the only one. PTBI's average 12-month price target comes in at $15.

  • During the past few months, RAD has been coming on strong, nearly doubling since its annual low of $4.42 in mid-October to close at $8.64 yesterday. The shares aren't slowing down yet. They're set to open 2.8% higher, after Credit Suisse reinstated coverage with an "outperform" rating. More bullish analyst attention may be on the way for Rite Aid Corporation, as it's nearing its multi-year high of $9.07 from early April. Interestingly, more and more traders have been shorting the stock, with short interest increasing over 12% during the most recent two-week reporting period. If RAD continues to rally and these bears make a quick exit, it could provide more fuel for its fire.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI